60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
1.780
-0.080 (-4.30%)
At close: Apr 6, 2026, 4:00 PM EDT
1.800
+0.020 (1.12%)
Pre-market: Apr 7, 2026, 7:06 AM EDT

SXTP Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5246--
Market Cap Growth
60.94%-35.33%-38.29%---
Enterprise Value
2.110.7611.5713.7300
Last Close Price
1.782.0325.80244.80--
PE Ratio
--0.17-0.35-1.03--
PS Ratio
3.331.685.3723.37--
PB Ratio
1.390.680.911.22--
P/TBV Ratio
0.340.390.730.83--
P/FCF Ratio
--0.34-0.64-1.29--
P/OCF Ratio
--0.35-0.65-1.30--
EV/Sales Ratio
1.497.6416.9854.14--
EV/EBITDA Ratio
--1.40-1.20-3.18--
EV/EBIT Ratio
--1.39-1.19-2.66--
EV/FCF Ratio
--1.54-2.01-2.98--
Debt / Equity Ratio
0.050.050.040.03-0.94-1.03
Debt / EBITDA Ratio
-0.02-0.02-0.02-0.04-44.62-42.00
Debt / FCF Ratio
-0.02-0.02-0.03-0.04-22.39-28.83
Net Debt / Equity Ratio
-0.31-0.31-0.39-0.40-0.95-1.48
Net Debt / EBITDA Ratio
0.140.140.160.46-44.10-41.74
Net Debt / FCF Ratio
0.160.160.270.43-22.13-28.66
Asset Turnover
0.250.250.100.060.383.18
Inventory Turnover
--1.650.960.720.98
Quick Ratio
141.44141.44197.040.840.010.41
Current Ratio
141.44141.44197.042.550.051.85
Return on Equity (ROE)
-200.93%-200.93%-181.78%39.42%29.21%15.93%
Return on Assets (ROA)
-139.47%-139.47%-143.47%-113.52%-130.10%-56.20%
Return on Invested Capital (ROIC)
-190.25%-190.25%-211.98%-190.59%-363.46%-130.16%
Return on Capital Employed (ROCE)
-139.69%-139.69%-181.61%58.32%16.01%-116.44%
Earnings Yield
-167.60%-576.92%-287.48%-96.70%--
FCF Yield
-148.91%-295.53%-157.28%-77.63%--
Buyback Yield / Dilution
-489.64%-489.64%-585.62%40.72%0.00%-6.71%
Total Shareholder Return
-489.64%-489.64%-585.62%40.72%0.00%-6.71%
Updated Mar 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q